FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
March 27, 2024
Share
FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) on March 28, 2024.
FSN Co Ltd, formerly FutureStream Networks Co Ltd, is a Korea-based company principally engaged in the digital marketing business. The Company operates its business through four segments. The AD Tech segment mainly operates advertisement platforms. The AD Agency segment mainly operates web and mobile advertisement production and agency business. The Overseas Business segment mainly operates mobile advertising and marketing business. The Other segment mainly operates media commerce and online to offline (O2O) business.
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
FSN CO., LTD. 
